Thereafter, the combination of a ptch mutation with inactivation of tumor suppressors, including TP53 or cyclin D-dependent kinase inhibitor p18Ink4c, was used to generate different SHH driven medulloblastoma models with shorter latency and higher penetrance (22, 55, 109). Here, TP53 is linked to neoplasm.